Animal models of liver regeneration.

Owing to its powers of regeneration, the liver is capable of in vivo "tissue engineering" which enables complete restoration of liver architecture and re-establishment of the specific functions of the liver after various types of liver injury. Our current understanding of liver regeneration forms the basis of modern liver surgery and is now taken into consideration in the treatment of many liver diseases, in liver transplantation and hepatic tissue engineering. These advances have been achieved primarily by studies of liver regeneration in animal models after partial hepatectomy, attention being focused on the general mechanisms of cell proliferation. In recent years, however, toxin-induced models of liver regeneration have assumed growing importance, and by studying the interaction between cell damage and cell regeneration have made possible an investigation of liver regeneration of greater clinical relevance. However, the mechanisms of liver regeneration in patients with pre-existing chronic liver damage such as liver cirrhosis are still largely unexplored. This review examines and critically appraises the various approaches to the study of liver regeneration in animal models, including both surgical and pharmacological approaches.

[1]  M. Holzman,et al.  SELECTIVE INTRAPORTAL HEPATOCYTE TRANSPLANTATION IN ANALBUMINEMIC AND GUNN RATS , 1993, Transplantation.

[2]  J. Rozga 50 – Animal Models of Liver Regeneration , 2001 .

[3]  R. Hernández-Muñoz,et al.  Morphological and Biochemical Effects of a Low Ethanol Dose on Rat Liver Regeneration Role of Route and Timing of Administration , 1999, Digestive Diseases and Sciences.

[4]  G. Bagby,et al.  Long‐term ethanol consumption alters the hepatic response to the regenerative effects of tumor necrosis factor‐α , 1993 .

[5]  P. Holt,et al.  Effect of acute ethanol administration upon hepatic regeneration. , 1979, The Journal of laboratory and clinical medicine.

[6]  L. Koniaris,et al.  Cytokine-Responsive Gene-2/IFN-Inducible Protein-10 Expression in Multiple Models of Liver and Bile Duct Injury Suggests a Role in Tissue Regeneration1 , 2001, The Journal of Immunology.

[7]  Jianpin Liu,et al.  Artificial and bioartificial support systems for liver failure. , 2004, The Cochrane database of systematic reviews.

[8]  M. Luster,et al.  Induction of early‐immediate genes by tumor necrosis factor α contribute to liver repair following chemical‐induced hepatotoxicity , 1997, Hepatology.

[9]  J. Terblanche,et al.  An animal model of fulminant hepatic failure: a feasibility study. , 1976, Gastroenterology.

[10]  J. D. Emerson,et al.  Effect of exchange transfusion on labeling of nuclei with thymidine-3-H and on mitosis in hepatocytes of normal and regenerating rat liver. , 1966, Cancer research.

[11]  Y. Watanabe Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). , 1980, Atherosclerosis.

[12]  U. Rasenack,et al.  Significance of endotoxaemia in experimental "galactosamine-hepatitis" in the rat. , 1977, Acta hepato-gastroenterologica.

[13]  A. Mclean,et al.  Effects of diet and microsomal enzyme induction on the toxicity of dimethyl nitrosamine. , 1969, British journal of experimental pathology.

[14]  K. Okita,et al.  Dexamethasone inhibits induction of liver tumor necrosis factor-alpha mRNA and liver growth induced by lead nitrate and ethylene dibromide. , 1994, The American journal of pathology.

[15]  S. Hirono,et al.  Expression of hepatocyte growth factor in normal and carbon tetrachloride–treated monkeys , 1994, Hepatology.

[16]  H. Gralnick,et al.  A model of fulminant hepatic failure in the rabbit , 1978 .

[17]  R Williams,et al.  Extracorporeal support and hepatocyte transplantation in acute liver failure and cirrhosis , 1999, Journal of gastroenterology and hepatology.

[18]  G. Maddern,et al.  The mystery of liver regeneration , 2002, The British journal of surgery.

[19]  M. Orloff 49 – Portal Hypertension and Portacaval Shunt* , 2001 .

[20]  D. Schuppan,et al.  Matrix as a modulator of hepatic fibrogenesis. , 2001, Seminars in liver disease.

[21]  R. Groszmann,et al.  Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[22]  L. Zieve,et al.  Acetaminophen liver injury: sequential changes in two biochemical indices of regeneration and their relationship to histologic alterations. , 1985, The Journal of laboratory and clinical medicine.

[23]  D. Rader,et al.  Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. , 1996, Annals of surgery.

[24]  J. Terblanche,et al.  A porcine model for the study of liver regeneration. , 1988, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[25]  J. Terblanche,et al.  Partial hepatectomy and liver regeneration in pigs--the response to different resection sizes. , 1988, The Journal of surgical research.

[26]  J. B. Simon Acetaminophen liver injury. , 1985, Canadian family physician Medecin de famille canadien.

[27]  A. M. Diehl,et al.  Liver Growth and Repair , 1998, Springer Netherlands.

[28]  S. Fan,et al.  Selective plasma filtration for treatment of fulminant hepatic failure induced by d-galactosamine in a pig model , 2002, Gut.

[29]  P. Dodd,et al.  Brain γ-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma γ-aminobutyric acid-like activity , 1987 .

[30]  S. Murphy,et al.  A comparison of the Ameroid constrictor versus ligation in the surgical management of single extrahepatic portosystemic shunts. , 2001, Journal of the American Animal Hospital Association.

[31]  D. G. Morgan,et al.  Ranitidine‐acetaminophen interaction: Effects on acetaminophen‐induced hepatotoxicity in fischer 344 rats , 1985, Hepatology.

[32]  D. Palmes,et al.  Liver bridging techniques in the treatment of acute liver failure. , 2000, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[33]  J. Najarian,et al.  Effects of intrasplenic injection of hepatocytes, hepatocyte fragments and hepatocyte culture supernatants on D-galactosamine-induced liver failure in rats. , 1983, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[34]  R. Hickman,et al.  The effect of prostaglandins, branched-chain amino acids and other drugs on the outcome of experimental acute porcine hepatic failure. , 1987, Journal of hepatology.

[35]  J. Díaz-Buxó,et al.  Galactosamine‐induced fulminant hepatic necrosis in unanesthetized canines , 1997, Hepatology.

[36]  K. Weinbren,et al.  THE MITOTIC RESPONSE IN THE RAT LIVER AFTER DIFFERENT REGENERATIVE STIMULI. , 1964, British journal of experimental pathology.

[37]  D. V. van Thiel,et al.  A dog model for acetaminophen-induced fulminant hepatic failure. , 1989, Gastroenterology.

[38]  H. Hodgson,et al.  Animal models of acute hepatic failure , 2000, International journal of experimental pathology.

[39]  R. Langer,et al.  Future directions in biomaterials. , 1990, Biomaterials.

[40]  J. Lunz,et al.  Concanavalin A simultaneously primes liver hematopoietic and epithelial progenitor cells for parallel expansion during liver regeneration after partial hepatectomy in mice , 2000, Hepatology.

[41]  O. Terpstra,et al.  Successful prolonged correction of an inborn metabolic defect by heterotopic auxiliary liver transplantation in a dog model. , 1993, Transplantation proceedings.

[42]  Stacy L. Haber,et al.  Comment: hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors. , 2002 .

[43]  Y. Israel,et al.  Long-term ethanol administration and short- and long-term liver regeneration after partial hepatectomy. , 1981, The Journal of laboratory and clinical medicine.

[44]  Steven D. Cohen,et al.  Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-alpha and interleukin-10. , 2002, Toxicology and Applied Pharmacology.

[45]  M. Czaja Liver regeneration following hepatic injury , 1998 .

[46]  I. Arias,et al.  Animal model of human disease. Crigler-Najjar Syndrome. Animal model: hereditary nonhemolytic unconjugated hyperbilirubinemia in Gunn rats. , 1972, The American journal of pathology.

[47]  T. Nakamura,et al.  Hepatocyte proliferation induced in rats by lead nitrate is suppressed by several tumor necrosis factor α inhibitors , 1996, Hepatology.

[48]  S. Thorgeirsson,et al.  Hepatic regeneration. The role of regeneration in pathogenesis of chronic liver diseases. , 1996, Clinics in laboratory medicine.

[49]  A. Diehl Effect of ethanol on tumor necrosis factor signaling during liver regeneration. , 1999, Clinical biochemistry.

[50]  A. Diehl,et al.  Nutrition, Hormones, Metabolism, and Liver Regeneration , 1991, Seminars in liver disease.

[51]  T Kiuchi,et al.  Auxiliary partial orthotopic living donor liver transplantation as an aid for small-for-size grafts in larger recipients. , 1999, Transplantation.

[52]  S. Bhatia,et al.  Advances in bioartificial liver devices , 2001, Hepatology.

[53]  J. Vacanti,et al.  Quantitation of transplanted hepatic mass necessary to cure the Gunn rat model of hyperbilirubinemia. , 1992, Journal of pediatric surgery.

[54]  G. Adam,et al.  Portale Kollateralenbildung nach Pfortaderligatur zur Leberregenerations-Induktion im Schweine-Modell , 2002 .

[55]  J. Albrecht,et al.  Arginine in thioacetamide‐induced hepatogenic encephalopathy in rats: activation of enzymes of arginine metabolism to glutamate , 1986, Acta neurologica Scandinavica.

[56]  D. Keppler,et al.  Galactosamine induced liver injury. , 1972, Progress in liver diseases.

[57]  D. Miller,et al.  Acinar distribution of liver cell regeneration after selective zonal injury in the rat. , 1978, Gastroenterology.

[58]  J. Emond,et al.  Overview of reduced-size liver transplantation. , 1991, Clinical transplantation.

[59]  Y. Sugiyama,et al.  Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride–intoxicated rats , 1993, Hepatology.

[60]  T. Nakamura,et al.  Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[61]  N. Bachur,et al.  Diurnal rhythm: effects on hepatic regeneration and hepatic regenerative stimulator substance. , 1978, Science.

[62]  G. Higgins,et al.  Experimental pathology of the liver , 1931 .

[63]  Schnittmengen der rekonstruktiven Chirurgie im Bereich der Regenerativen Medizin , 2002, Der Chirurg.

[64]  W. E. van den Brom,et al.  Progressive remission of portosystemic shunting in 23 dogs after partial closure of congenital portosystemic shunts , 1999, Veterinary Record.

[65]  J R Lake,et al.  Functional analysis of grafts from living donors. Implications for the treatment of older recipients. , 1996, Annals of surgery.

[66]  T. Aikou,et al.  Exogenous hepatocyte growth factor markedly stimulates liver regeneration following portal branch ligation in dogs , 1996, Cancer Chemotherapy and Pharmacology.

[67]  S. Strom,et al.  Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. , 1998, The New England journal of medicine.

[68]  N. Bucher,et al.  Accelerated response of hepatic DNA synthesis to partial hepatectomy in rats pretreated with growth hormone or surgical stress. , 1970, Cancer research.

[69]  Jianpin Liu,et al.  Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol. , 2002, Liver.

[70]  A. Columbano,et al.  Liver regeneration versus direct hyperplasia , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[71]  J. Emond,et al.  Application of Reduced‐size Liver Transplants as Split Grafts, Auxiliary Orthotopic Grafts, and Living Related Segmental Transplants , 1990, Annals of surgery.

[72]  J. Blanchard,et al.  Liver regeneration investigated in a non-human primate model (Macaca mulatta). , 2002, Journal of hepatology.

[73]  C. Sotelo‐Avila,et al.  Cholestasis without cirrhosis alters regulatory liver gene expression and inhibits hepatic regeneration. , 1991, Surgery.

[74]  P. Wagner,et al.  The effect of chronic ethanol feeding on ornithine decarboxylase activity and liver regeneration , 1988, Hepatology.

[75]  S. Nagase,et al.  Albumin-deficient rat mutant. , 1979, Science.

[76]  M. Nishida,et al.  Introduction of monoclonal antibodies to bromodeoxyuridine to monitor hepatic regeneration. , 1991, Gastroenterology.

[77]  Y. Ku,et al.  Preoperative hepatic venous embolization for partial hepatectomy combined with segmental resection of major hepatic vein , 2002, The British journal of surgery.

[78]  Robert Langer,et al.  Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation , 1999, The Lancet.

[79]  H. Tsukamoto,et al.  Experimental Models of Hepatic Fibrosis: A Review , 1990, Seminars in liver disease.

[80]  G. Michalopoulos,et al.  Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration , 1991, Hepatology.